Altogether, this study demonstrates that APB enhances Dox efficacy by disrupting AGS cell homeostasis at multiple levels, supporting its potential role as a promising adjuvant strategy in gastric cancer therapy. The gene discussed is RNPEP; the disease is gastric cancer.